Stem Cell Market 2024 – Market Brief Analysis, Market Size, Top Leading Companies, Segmentation | Danaher Corporation, Cryo-Cell International Inc., Daiichi Sankyo Company Limited, Lonza Group Ltd., PerkinElmer Inc.bia and Cornell, Johns Hopkins Hospital

The Stem Cell Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Stem Cell Market:
https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

According to The Business Research Company’s Stem Cell Global Market Report 2024, The stem cell market size has grown strongly in recent years. It will grow from $13.97 billion in 2023 to $15.34 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to advancements in regenerative medicine, growing prevalence of chronic diseases, research and development initiatives, increasing aging population, rising awareness and acceptance.

The stem cell market size is expected to see rapid growth in the next few years. It will grow to $23.13 billion in 2028 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to expanding applications in oncology, innovations in personalized medicine, government support and funding, biotechnology collaborations and partnerships, clinical trials and regulatory approvals. Major trends in the forecast period include commercialization of stem cell therapies, application of crispr technology, regulatory framework development, investments in stem cell research, focus on exosome therapeutics.

There is an increase in the prevalence of Chronic diseases worldwide which drives the Stem cell market. Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use. Currently, widely used stem cell treatment is the transplantation of blood stem cells to treat diseases and conditions of the blood and immune system, or to restore the blood system after treatments for specific cancers. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, the number of people with chronic diseases worldwide is projected to reach 142.66 million by the year 2050, which is an increase from 71.522 million in 2020.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=2584&type=smp

The stem cell market covered in this report is segmented –
1) Stem Cell Market By Source: Autologous, Allogeneic
2) Stem Cell Market By Product Type: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, Other Products
3) Stem Cell Market By Application: Regenerative Medicine, Drug Discovery And Development

Top Major Players

Danaher Corporation

Cryo-Cell International Inc.

Daiichi Sankyo Company Limited

Lonza Group Ltd.

PerkinElmer Inc.bia and Cornell

Companies in the stem cell therapeutics market are focusing on development of new technologies such as the Induced Pluripotent Stem Cells (IPSC) to boost the efficiency of stem cell therapies. IPSC are obtained from blood or skin cells that are reprogrammed to an embryonic-like pluripotent state by incorporating genes that are essential for maintaining key properties and growth of an unlimited source of any kind of human cell required for stem cell therapeutic purposes. These IPSC’s are not derived from human embryos, which removes the bioethical issues, thus allowing scientists to obtain federal funding and support easily. A Japanese company, Oksara opened a medicine center that produced cells derived from iPS Cells. Similarly, Takar Bio company launched human iPSC derived Beta Cells i.e., Cellartis for disease modeling and drug discovery.

The stem cell market report table of contents includes:

1. Executive Summary

2. Stem Cell Market Characteristics

3. Stem Cell Market Trends And Strategies

4. Stem Cell Market – Macro Economic Scenario

5. Global Stem Cell Market Size and Growth

…..

32. Global Stem Cell Market Competitive Benchmarking

33. Global Stem Cell Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Stem Cell Market

35. Stem Cell Market Future Outlook and Potential Analysis

36. Appendix

Read Related Reports:

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model